Products & Services Investor relations
About Cerep News Events & MeetingsContacts Downloads FAQs
Cerep home
Your data onlineCatalog online
Home > News > Publications > Journal publications
Journal publications
2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004-1991
Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium
Waterbury D.L., Silliman D., Jolas T.
Current medical research and opinion, Vol. 22, No. 6, 2006, 1133–1140

Construction of a homogeneous and informative in vitro profiling database for anticipating the clinical effects of drugs
Froloff N., Hamon V., Dupuis P., Otto-Bruc A., Mao B., Merrick S. and Migeon J.
In: Jacoby, E. (Ed.), Chemogenomics Knowledge-based Approaches to Drug Discovery, Imperial College Press, London, pp. 175-206.

Discovery and development of 5-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl-methyl]-3-thiophenecarboxylic acid (BMS-587101): A small molecule antagonist of leukocyte function associated antigen-1
Potin, D., Launay M., Monatlik F., Malabre P., Fabreguettes M., Fouquet A., Maillet M., Nicolai E., Dorgeret L., Chevallier F., Besse D., Dufort M., Caussafe F., Ahmad S.Z., Stetsko DK., Skala S., Davis PM., Balimane P., Patel K., Yang Z., Marathe P., Postelneck J., Townsend RM., Goldfarb V., Sheriff S., Einspahr H., Kish K., Malley MF., Di Marco JD., Gougoutas JZ., Kadiyala P., Cheney DL., Tejwani RW., Murphy DK., McIntyre KW., Yang X., Chao S., Leith L., Xiao Z., Mathur A., Chen BC., Wu DR., Traeger SC., McKinnon M., Barrish JC., Robl JA., Iwanowicz EJ., Suchard SJ., Dhar TG.
J. Med. Chem., 49 (24): 6946-6949

Fuzzy Tricentric Pharmacophore Fingerprints. Topological Fuzzy Pharmacophore Triplets and Adapted Molecular Similarity Scoring Schemes
Bonachéra, F., Parent, B., Barbosa, F., Froloff, N. & Horvath, D.
Journal of Chemical Information and Modeling, 46, 2457-2477

High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model usign high content screening
P.J. O'Brien, W. Irwin, D. Diaz, E. Howard-Cofield, C.M. Kresja, M.R. Slaughter, B. Gao, N. Kaludercic, A. Angline, P. Bernardi, P. Brain, C. Hougham
Arch. Toxicol (2006), DO1 10.1007/s00204-006-0091-3

Identifying human toxicity potential: Defining the Sequence of Events in Statin Toxicity using a High Content Cytotoxicity Assay
Diaz, D. and O’Brien, P.J.
European Pharmaceutical review, 11, 4, 38-45

QSAR modeling of in vitro inhibition of cytochrome P450 3A4
Mao, B., Gozalbes, R., Barbosa, F., Migeon, J., Merrick, S., Kamm, K., Wong, E., Costales, C., Shi, W., Wu, C. & Froloff, N.
Journal of Chemical Information and Modeling, 46, 2125-2134

The BioPrint Approach for the Evaluation of ADME Properties: Application to the Prediction of Cytochrome P450 2D6 Inhibition
Gozalbes R., Barbosa F., Froloff N., Horvath D.
Book Chapter in the Monograph: Pharmacokinetic Profiling in Drug Research, Chapt 23, pp395-415

The BioPrint® approach for the evaluation of ADMET properties: application to the prediction of cytochrome P450 2D6 inhibition.
Gozalbes, R., Barbosa, F., Froloff, N. & Horvath, D
Testa, B., Krämer, S.D., Wunderli-Allenspach, H. & Folkers, G. (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, VHCA, Zürich, WILEY-VCH, Weinheim, pp. 395-415

Press releases
New products
& services

Poster presentations
Journal publications
Français :: Chinese :: Home :: Site map :: Legal notice :: Credits ::